News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Silk Road Medical Inc
(NQ:
SILK
)
27.09
+0.03 (+0.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silk Road Medical Inc
< Previous
1
2
3
4
5
6
Next >
Silk Road Medical Reports Third Quarter 2022 Financial Results
November 08, 2022
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical's Earnings: A Preview
November 07, 2022
Silk Road Medical (NASDAQ:SILK) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Silk Road...
Via
Benzinga
Silk Road Medical to Present at Upcoming Investor Conferences
November 03, 2022
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022
October 25, 2022
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical's Q2 Margins Hit By Manufacturing Expansion Costs
July 27, 2022
Via
Benzinga
Earnings Scheduled For July 26, 2022
July 26, 2022
Companies Reporting Before The Bell • General Motors (NYSE:GM) is likely to report quarterly earnings at $1.30 per share on revenue of $34.59 billion.
Via
Benzinga
Analyst Ratings for Silk Road Medical
May 17, 2022
Silk Road Medical (NASDAQ:SILK) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Silk Road Medical Announces Pricing of Public Offering
October 18, 2022
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical Announces Certain Preliminary Financial Data For Quarter Ended September 30, 2022
October 17, 2022
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical Announces Proposed Public Offering of Common Stock
October 17, 2022
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical Stock Scores Relative Strength Rating Upgrade
September 28, 2022
Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level.
Via
Investor's Business Daily
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
Via
Benzinga
Silk Road Medical Reports Second Quarter 2022 Financial Results
July 26, 2022
From
Silk Road Medical
Via
GlobeNewswire
Earnings Preview: Silk Road Medical
July 25, 2022
Silk Road Medical (NASDAQ:SILK) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here's what investors need to know before the announcement. Analysts estimate that Silk Road...
Via
Benzinga
Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
July 22, 2022
Silk Road Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 90.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022
July 11, 2022
Upgrades
Via
Benzinga
'Let's Just Stick With Morgan Stanley': Why Jim Cramer Says No To These Bank Stocks
June 28, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Belden (NYSE: BDC) over Encore Wire Corp (NASDAQ: WIRE).
Via
Benzinga
66 Biggest Movers From Yesterday
May 03, 2022
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...
Via
Benzinga
31 Stocks Moving In Monday's Mid-Day Session
May 02, 2022
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) climbed 64.9% to $9.86. Redbox recently reported CFO transition. SoundHound AI, Inc. (NASDAQ: SOUN) shares gained 30.5% to $8.48...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
April 06, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 24, 2022
Gainers Unicycive Therapeutics (NASDAQ:UNCY
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
Earnings Preview For Silk Road Medical
February 23, 2022
Silk Road Medical (NASDAQ:SILK) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Silk Road Medical, inc (SILK) Q3 2021 Earnings Call Transcript
November 10, 2021
SILK earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
63 Biggest Movers From Friday
August 02, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.